↓ Skip to main content

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy

Overview of attention for article published in Arthritis Research & Therapy, December 2008
Altmetric Badge

Mentioned by

wikipedia
8 Wikipedia pages

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
65 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
Published in
Arthritis Research & Therapy, December 2008
DOI 10.1186/ar2570
Pubmed ID
Authors

Pascale Nicaise Roland, Sabine Grootenboer Mignot, Alessandra Bruns, Margarita Hurtado, Elisabeth Palazzo, Gilles Hayem, Philippe Dieudé, Olivier Meyer, Sylvie Chollet Martin

Abstract

Antibodies against cyclic citrullinated peptides (CCPs) are useful for diagnosing rheumatoid arthritis (RA). Antibodies to mutated citrullinated vimentin (MCV) were described recently in RA. The aims of this study were to evaluate the usefulness of anti-MCV for diagnosing RA in anti-CCP-negative patients and to monitor anti-MCV titres during infliximab therapy for RA.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 2%
Germany 1 2%
United Kingdom 1 2%
Egypt 1 2%
Russia 1 2%
United States 1 2%
Unknown 59 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 15%
Student > Master 10 15%
Researcher 7 11%
Student > Bachelor 6 9%
Other 6 9%
Other 12 18%
Unknown 14 22%
Readers by discipline Count As %
Medicine and Dentistry 22 34%
Agricultural and Biological Sciences 8 12%
Immunology and Microbiology 5 8%
Nursing and Health Professions 2 3%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 9 14%
Unknown 17 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2023.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from Arthritis Research & Therapy
#1,710
of 3,381 outputs
Outputs of similar age
#51,402
of 179,045 outputs
Outputs of similar age from Arthritis Research & Therapy
#5
of 15 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,045 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.